Scripps’ outside phone carrier is experiencing an outage that is affecting some phone lines and faxes. Temporary phone numbers are listed on our Contact Us page. We apologize for any inconvenience and will provide updates as they are available.

Your browser is out-of-date!

Internet Explorer 11 has been retired by Microsoft as of June 15, 2022. To get the best experience on this website, we recommend using a modern browser, such as Safari, Chrome or Edge.


Scripps Health's Eric Topol on Statins and Diabetes Risk

Eric topol md 2010

What is more important: The benefit of taking a cholesterol-lowering statin drug to protect against heart attacks and strokes, or the increased risk of developing diabetes that might accompany the medication in some patients?

While a new study concluded that the heart-disease prevention benefits outweigh the diabetes risk, Scripps Clinic cardiologist Eric Topol, M.D., continues to warn against over prescribing the popular drugs.

“Although there is a narrow trade-off with the benefits of reducing heart disease, this paper doesn’t mitigate the (diabetes) concern to me,” the Scripps Health chief academic officer told The Wall Street Journal in a recent article about the study.

Dr. Topol also weighed in on the controversy in coverage by USA Today and The Boston Globe.

Read those full articles here:

USA Today – Aug. 10

The Boston Globe – Aug. 10

Media Contact

Keith Darce